Vonjo was also shown to improve overall survival in patients with myelofibrosis treated with Vonjo in the real-world setting. Improvements in thrombocytopenia and anemia were observed in patients with ...

Microangiopathic Hemolytic Anemia and Thrombocytopenia in Patients With Cancer The following represents disclosure information provided by authors of this manuscript. All relationships are considered ...

A recently published report describes the diagnosis and treatment of a case of iron-deficiency anemia–associated thrombocytopenia secondary to recurrent nosebleeds. While thrombocytosis is known to be ...

Real-world data on momelotinib shows improved hemoglobin levels and transfusion independence in MF patients with anemia, surpassing previous clinical trial results. By six months, 45.7% of patients ...

A successful multifaceted intervention to reduce postpartum hemorrhage (PPH) and maternal mortality (MM) in Sub-Saharan Africa — and the related confirmation of a link between prenatal anemia and PPH ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that ...

In patients with cancer, systemic microvascular metastases and bone marrow involvement can cause microangiopathic hemolytic anemia and thrombocytopenia. This occurs most often in patients with known ...